Cargando…

mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection

Hydrogen sulfide (H(2)S) is known to have cardiac protective effects through Akt activation. Akt acts as a ‘central sensor’ for myocyte survival or death; its activity is regulated by multiple kinases including PI3K, mTORC2, PDK1 and phosphatases including PTEN, PP2A and PHLPPL. Based on the previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yue, Wang, Daying, Gao, Xiufang, Lew, Karsheng, Richards, Arthur Mark, Wang, Peipei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064967/
https://www.ncbi.nlm.nih.gov/pubmed/24949720
http://dx.doi.org/10.1371/journal.pone.0099665
_version_ 1782322003821199360
author Zhou, Yue
Wang, Daying
Gao, Xiufang
Lew, Karsheng
Richards, Arthur Mark
Wang, Peipei
author_facet Zhou, Yue
Wang, Daying
Gao, Xiufang
Lew, Karsheng
Richards, Arthur Mark
Wang, Peipei
author_sort Zhou, Yue
collection PubMed
description Hydrogen sulfide (H(2)S) is known to have cardiac protective effects through Akt activation. Akt acts as a ‘central sensor’ for myocyte survival or death; its activity is regulated by multiple kinases including PI3K, mTORC2, PDK1 and phosphatases including PTEN, PP2A and PHLPPL. Based on the previous finding that PI3K inhibitor LY294002 abolishes H(2)S-induced Akt phosphorylation and cardioprotection, it is accepted that PI3K is the mediator of H(2)S-induced Akt phosphorylation. However, LY294002 inhibits both PI3K and mTOR, and PI3K only recruits Akt to the membrane where Akt is phosphorylated by Akt kinases. We undertook a series of experiments to further evaluate the role of mTORC2, PDK1, PTEN, PP2A and PHLPPL in H(2)S-induced Akt phosphorylation and cardioprotection, which, we believe, has not been investigated before. Hearts from adult Sprague-Dawley rats were isolated and subjected to (i) normoxia, (ii) global ischemia and (iii) ischemia/reperfusion in the presence or absence of 50 µM of H(2)S donor NaHS. Cardiac mechanical function and lactate dehydrogenase (LDH) release were assessed. All hearts also were Western analyzed at the end of perfusion for Akt and a panel of appropriate Akt regulators and targets. Hearts pretreated with 50 µM NaHS had improved function at the end of reperfusion (Rate pressure product; 19±4×10(3) vs. 10±3×10(3) mmHg/min, p<0.05) and reduced cell injury (LDH release 19±10 vs. 170±87 mU/ml p<0.05) compared to untreated hearts. NaHS significantly increased phospho-Akt, phospho-mTOR, phospho-Bim and Bcl-2 in reperfused hearts (P<0.05). Furthermore using H9c2 cells we demonstrate that NaHS pretreatment reduces apoptosis following hypoxia/re-oxygenation. Importantly, PP242, a specific mTOR inhibitor, abolished both cardioprotection and protein phosphorylation in isolated heart and reduced apoptotic effects in H9c2 cells. Treating hearts with NaHS only during reperfusion produced less cardioprotection through a similar mechanism. These data suggest mTORC2 phosphorylation of Akt is a key mediator of H(2)S-induced cardioprotection in I/R.
format Online
Article
Text
id pubmed-4064967
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40649672014-06-25 mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection Zhou, Yue Wang, Daying Gao, Xiufang Lew, Karsheng Richards, Arthur Mark Wang, Peipei PLoS One Research Article Hydrogen sulfide (H(2)S) is known to have cardiac protective effects through Akt activation. Akt acts as a ‘central sensor’ for myocyte survival or death; its activity is regulated by multiple kinases including PI3K, mTORC2, PDK1 and phosphatases including PTEN, PP2A and PHLPPL. Based on the previous finding that PI3K inhibitor LY294002 abolishes H(2)S-induced Akt phosphorylation and cardioprotection, it is accepted that PI3K is the mediator of H(2)S-induced Akt phosphorylation. However, LY294002 inhibits both PI3K and mTOR, and PI3K only recruits Akt to the membrane where Akt is phosphorylated by Akt kinases. We undertook a series of experiments to further evaluate the role of mTORC2, PDK1, PTEN, PP2A and PHLPPL in H(2)S-induced Akt phosphorylation and cardioprotection, which, we believe, has not been investigated before. Hearts from adult Sprague-Dawley rats were isolated and subjected to (i) normoxia, (ii) global ischemia and (iii) ischemia/reperfusion in the presence or absence of 50 µM of H(2)S donor NaHS. Cardiac mechanical function and lactate dehydrogenase (LDH) release were assessed. All hearts also were Western analyzed at the end of perfusion for Akt and a panel of appropriate Akt regulators and targets. Hearts pretreated with 50 µM NaHS had improved function at the end of reperfusion (Rate pressure product; 19±4×10(3) vs. 10±3×10(3) mmHg/min, p<0.05) and reduced cell injury (LDH release 19±10 vs. 170±87 mU/ml p<0.05) compared to untreated hearts. NaHS significantly increased phospho-Akt, phospho-mTOR, phospho-Bim and Bcl-2 in reperfused hearts (P<0.05). Furthermore using H9c2 cells we demonstrate that NaHS pretreatment reduces apoptosis following hypoxia/re-oxygenation. Importantly, PP242, a specific mTOR inhibitor, abolished both cardioprotection and protein phosphorylation in isolated heart and reduced apoptotic effects in H9c2 cells. Treating hearts with NaHS only during reperfusion produced less cardioprotection through a similar mechanism. These data suggest mTORC2 phosphorylation of Akt is a key mediator of H(2)S-induced cardioprotection in I/R. Public Library of Science 2014-06-20 /pmc/articles/PMC4064967/ /pubmed/24949720 http://dx.doi.org/10.1371/journal.pone.0099665 Text en © 2014 Zhou et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zhou, Yue
Wang, Daying
Gao, Xiufang
Lew, Karsheng
Richards, Arthur Mark
Wang, Peipei
mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection
title mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection
title_full mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection
title_fullStr mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection
title_full_unstemmed mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection
title_short mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection
title_sort mtorc2 phosphorylation of akt1: a possible mechanism for hydrogen sulfide-induced cardioprotection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064967/
https://www.ncbi.nlm.nih.gov/pubmed/24949720
http://dx.doi.org/10.1371/journal.pone.0099665
work_keys_str_mv AT zhouyue mtorc2phosphorylationofakt1apossiblemechanismforhydrogensulfideinducedcardioprotection
AT wangdaying mtorc2phosphorylationofakt1apossiblemechanismforhydrogensulfideinducedcardioprotection
AT gaoxiufang mtorc2phosphorylationofakt1apossiblemechanismforhydrogensulfideinducedcardioprotection
AT lewkarsheng mtorc2phosphorylationofakt1apossiblemechanismforhydrogensulfideinducedcardioprotection
AT richardsarthurmark mtorc2phosphorylationofakt1apossiblemechanismforhydrogensulfideinducedcardioprotection
AT wangpeipei mtorc2phosphorylationofakt1apossiblemechanismforhydrogensulfideinducedcardioprotection